myBrain Technologies
myBrain Technologies is a Paris-based private company that builds an AI-powered EEG brain-analysis platform (myBrain Tech) with a Class IIa headset (Q+ Medical) and validated Neuromarkers, sold to healthcare providers for remote patient monitoring and to cosmetics, nutraceutical, automotive, and academic clients for sensory and consumer-experience research.
- Company typePrivate
- Founded2014
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
myBrain Technologies firmographics
Firmographics- Name
- myBrain Technologies
- Legal name
- myBrain Technologies
- Website
- https://mybraintech.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- myBrain Technologies is a Paris-based private company that builds an AI-powered EEG brain-analysis platform (myBrain Tech) with a Class IIa headset (Q+ Medical) and validated Neuromarkers, sold to healthcare providers for remote patient monitoring and to cosmetics, nutraceutical, automotive, and academic clients for sensory and consumer-experience research.
- Ownership category
- akta.pro rank
myBrain Technologies industry classification
Industry- Product category
- EEG Brain Monitoring Platform
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Scientific and Technical Consulting Services (54169), Marketing Research and Public Opinion Polling (541910)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ), Behavioral & Neuroscience Research (Biometrics, Eye-Tracking, Neuromarketing) (MPAAALAN), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where myBrain Technologies is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
myBrain Technologies business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Remote Patient Monitoring (RPM) Solutions: SaaS-based neuro-AI platform for healthcare providers to monitor patient brain activity. The platform combines high-quality brain data with accurate physiological data to provide insights about patient brains for mental health, oncology, and CNS disease applications.
- Sensory/Neuroanalytics Services: EEG-based brain analysis services for cosmetics, nutrition, automotive, and academic clients to assess product effects on brain activity and consumer behavior. Services include customized protocols with cognitive tasks, surveys, and neuromarker analysis.
- Medical Device Sales: Sale of Q+ Medical Class IIa EEG hardware devices and associated software for brain monitoring in clinical and healthcare settings.
- Cosmetics Research Services: Neuroscience-driven testing services for cosmetic companies including emotional response assessment, relaxation quantification, and consumer experience analysis using EEG technology.
- Nutraceutical Research Services: EEG-based clinical study services for nutraceutical companies to assess product efficacy on cognitive health, stress levels, and sleep quality through neuromarker analysis.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
myBrain Technologies product offering
Product offeringCore offering
myBrain Technologies develops a Neuro-AI powered brain analysis platform that combines EEG neuroimaging with artificial intelligence algorithms to record, analyse, and interpret brain electrical signals in real time. The platform is delivered through a SaaS dashboard with validated digital Neuromarkers (relaxation, attention, mental workload, emotional valence, arousal) and is paired with a Class IIa clinical-grade EEG headset (Q+ Medical) used for remote patient monitoring in mental health, CNS diseases, and oncology. The same platform powers sensory/neuroanalytics research services for cosmetics, nutrition, automotive and academic clients to objectively measure consumer and subject brain responses.
Product overview
myBrain Technologies offers an AI-powered brain data platform (myBrain Tech) consisting of a SaaS cloud analytics platform, a miniaturised EEG headset (Q+ Medical, Class IIa), and validated Neuromarkers. The platform delivers real-time recording, analysis, and interpretation of brain electrical signals for two primary markets: Remote Patient Monitoring (RPM) in healthcare (mental health, CNS diseases, oncology) and Sensory Research across industries (cosmetics, nutraceuticals, automotive, academics, clinical). Key product components include the myBrain Tech SaaS dashboard with Neuromarkers analytics (emotions, relaxation, attention, mental workload), the Q+ Medical EEG hardware, the Global Brain Assessment Program for configurable sensory testing protocols, and dedicated sensory testing solutions for cosmetics and nutrition verticals. The company was founded as a spin-off from the Paris Brain Institute (ICM) and holds ISO 13485:2016 certification as a medical device manufacturer.
Differentiator
Problem solved
Functional benefit
Brands
- Q+ Medical: Class IIa medical device consisting of EEG data measurement designed to monitor brain wave oscillations of patients with mental health and neurological disorders.
- myBrain Technologies Platform
- melomind
Products and services
- myBrain Tech Platform SaaS Neuro-AI brain analysis platform that records, analyses, and interprets brain electrical signals in real time through a user-friendly dashboard, delivering digital Neuromarkers (relaxation, attention, mental workload, emotional valence, arousal) to healthcare providers and industry clients.
- Q+ Medical Class IIa medical device consisting of a simplified, non-invasive, clinical-grade EEG headset and interpretation software designed to monitor brain wave oscillations of patients with mental health and neurological disorders (CE certification in progress).
- Remote Patient Monitoring (RPM) Brain-based remote patient monitoring solution combining high-quality EEG brain data with accurate physiological data to support patients throughout their care journey, targeting mental health, oncology, and CNS diseases, with 3-step patient monitoring workflow (onboarding, high-quality EEG recording, dashboard-based follow-up).
- Sensory Research Platform EEG-based sensory testing platform giving industry direct access to consumer and subject brain data for cosmetics, nutrition, automotive, academic, and clinical research, enabling measurement of emotional responses, relaxation, and cognitive performance.
- Cosmetics Sensory Testing EEG-based in-vivo testing service for cosmetics companies to assess emotional valence, arousal, and relaxation neuromarkers of consumers and evaluate the impact of skincare, fragrance, and active ingredients on human cognition and physiology.
- Nutrition Sensory Testing EEG-powered sensory testing service for the nutraceutical industry, combining brain data with sleep sensors, medical surveys, heart rate variability, and other physiological data to prove efficacy of food supplements on cognitive health, stress, and sleep quality.
Quantifiable outcome
- Improve population health management outcomes
- +3 more outcomes
Companies that use myBrain Technologies
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles5 records
myBrain Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature8 records
myBrain Technologies partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- ValeocoremyBrain Technologies was selected by CORAM to collaborate with Valeo on the SERENITE Project in 2021. The partnership aims to build human-oriented AI capable of quantifying and predicting drivers' states (fatigue, attention, emotions) while interacting with autonomous and connected vehicles in diverse driving experiences. The collaboration capitalizes on myBrain Technologies' neuromarkers platform.
- ClariantcoreTrusted partnership where Clariant sought to assess an active skincare cream ingredient's impact on users' cognition. The collaboration revealed benefits on neuromarkers of relaxation and emotion, demonstrating promising insights for the cosmetics industry seeking relaxing innovations.
- Cosmetic ValleyminormyBrain Technologies attended the 5th Congress of Cosmetic Valley on 'Olfaction and Perspectives', connecting with experts in the field and sharing insights about the added value the company brings to product development in cosmetics.
- FaureciacoreFaurecia, a global leader of the automotive equipment market, used myBrain Technologies' wireless EEG headset with eight dry electrodes to conduct research on thermal comfort in car seats. The study validated EEG-based indexes correlated with thermal comfort modulations, demonstrating the positive impact of Faurecia's ventilating system on seat occupant comfort.
- Digital Pharma LabminormyBrain Technologies participated in the 4th Webinar #PharmaTalk organized by Digital Pharma Lab, discussing 'AI, conquering emotions in Health!' with Giuseppe Spinelli and Antoine Groheux.
- CORAMcoreCORAM selected the SERENITE Project led by Valeo with myBrain Technologies as a key partner for human-oriented AI development in autonomous vehicles.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
myBrain Technologies competitors and assessment
Company assessmentDirect peers
- EMOTIV: EMOTIV makes consumer and research EEG headsets with cloud-based brain data analytics and a developer ecosystem. It is the most direct competitor to myBrain's EEG-plus-AI platform, serving overlapping segments in academic research, neurogaming, and consumer wellbeing.
- Muse (Interaxon): Muse produces consumer EEG headbands for meditation and focus, with a subscription app for brain-data feedback. It competes with myBrain's Melomind device and neuromarker-based mental wellness offerings, particularly in the at-home and consumer mental health segment.
- NeuroSky: NeuroSky manufactures low-cost EEG biosensors and chipsets used in consumer wellness, education, and research applications. It overlaps with myBrain's mission of democratising EEG access via simplified hardware and AI-driven interpretation.
- BioSerenity: BioSerenity develops wearable EEG systems for neurology diagnostics, including epilepsy and sleep monitoring, with hospital and clinical trial channels. It is a direct medical-grade EEG competitor for myBrain's RPM and clinical neurology use cases.
Broad incumbents
- Brain Products: Brain Products is an established manufacturer of high-quality research-grade EEG systems and software (BrainVision). It competes with myBrain in academic and clinical research markets, with a broader legacy product portfolio but less focus on AI-driven neuromarkers.
- Compumedics: Compumedics is a global medical device company specialising in sleep diagnostics, neurology, and brain monitoring. Its neurology and long-term EEG monitoring portfolio overlaps with myBrain's CNS disease and clinical RPM applications.
- ANT Neuro: ANT Neuro provides high-end EEG, MEG, and TMS systems for clinical and research applications. It is comparable to myBrain's academic and clinical verticals, with a deeper research-customer base but a less consumer-friendly hardware/AI offering.
Emerging players
- Neurable: Neurable builds EEG-based brain-computer interface technology for consumer and enterprise applications, including productivity and focus tracking. It overlaps with myBrain's neuromarker work on attention and mental workload, particularly in the automotive and workplace monitoring segments.
- Beacon Biosignals (Dreem): Beacon Biosignals (formerly Dreem) uses EEG for sleep and neurological disorder biomarkers, with pharma clinical trial partnerships. Its sleep and CNS biomarker focus parallels myBrain's CNS disease and CNS clinical trial roadmap.
Others
- iMotions: iMotions is a human behaviour research platform that integrates EEG, eye-tracking, GSR, and facial coding for consumer and academic research. It is comparable to myBrain's sensory research solutions for cosmetics, nutrition, and automotive use cases, especially on the software/integrator side.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
myBrain Technologies social profiles
Digital presencemyBrain Technologies compliance and trust
Trust signalCompliance4 records
myBrain Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
myBrain Technologies leadership team
Management profileNumber of profiles
Profiles5 records
myBrain Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
myBrain Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about myBrain Technologies
What does myBrain Technologies do?
myBrain Technologies develops a Neuro-AI powered brain analysis platform that combines EEG neuroimaging with artificial intelligence algorithms to record, analyse, and interpret brain electrical signals in real time. The platform is delivered through a SaaS dashboard with validated digital Neuromarkers (relaxation, attention, mental workload, emotional valence, arousal) and is paired with a Class IIa clinical-grade EEG headset (Q+ Medical) used for remote patient monitoring in mental health, CNS diseases, and oncology. The same platform powers sensory/neuroanalytics research services for cosmetics, nutrition, automotive and academic clients to objectively measure consumer and subject brain responses.
Is myBrain Technologies a public or private company?
myBrain Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was myBrain Technologies founded?
myBrain Technologies was founded in 2014. It employs 11 to 50 people.
Where is myBrain Technologies based?
myBrain Technologies is headquartered in Paris, France, in the Europe region.
How does myBrain Technologies make money?
Five revenue lines are on record. Remote Patient Monitoring (RPM) Solutions are the primary driver. The others are sensory/Neuroanalytics Services, medical Device Sales, cosmetics Research Services and nutraceutical Research Services.
Who are myBrain Technologies's main competitors?
Direct peers on record are EMOTIV, Muse (Interaxon), NeuroSky and BioSerenity. Broad incumbents are Brain Products, Compumedics and ANT Neuro. Emerging players are Neurable and Beacon Biosignals (Dreem). iMotions is listed as an others.
Does myBrain Technologies have an API?
Yes. The ILab API enables integration of external data into programs to correlate EEG data with other information sources such as data from other sensors, subject metadata, and data from other digital tools. Developer documentation is at Not specified.
What industry is myBrain Technologies in?
myBrain Technologies's product category is EEG Brain Monitoring Platform. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 3845.